Longduoduo Co Ltd (LDDD) stock

LDDDOTCServices-Health ServicesFiscal year ends June 30

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 30, 2026Score 7/30

$0.51+0.00 (0.00%)

Close on Oct 16, 2026Market cap $15.31MP/E –Yield –

Longduoduo price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Longduoduo's price to sales ratio was 8.4× on Oct 16, 2026, against 6.6× a year earlier. Over the last 3 years it ranged from 4.3× to 66.0×, with a median of 21.4×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 16, 2026	8.4×	+4.1
2025	Dec 31, 2025	4.3×	−20.7
2024	Dec 31, 2024	25.0×	−16.0
2023	Dec 29, 2023	41.0×	–

Where these numbers come from

Parsed from the XBRL in Longduoduo's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 27, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LDDD.

Compare: LDDD vs ATPC · LDDD vs EUDA · LDDD vs ALPS · LDDD vs AAQL · LDDD vs MCTA

Revenue growth-57.2% · median 21.0%

Gross margin99.1% · median 54.4%

Operating margin-34.7% · median -170.3%

Net margin-31.8% · median -84.8%

Company	Revenue	Growth
LDDD	$1.82M	-57.2%
AAQL	$1.47M	+62.4%
ATPC	$1.15M	-20.3%
EUDA	–	–
ALPS	–	–
MCTA	–	–

Company

Exchange: OTC
Industry: Services-Health Services
Fiscal year ends: June 30
Employees: 51
Auditor: Bush & Associates CPA LLC
SEC CIK: 1892316

Advertisement
300 × 250

See a number that looks wrong?

Longduoduo price to sales ratio

Price to Sales Ratio at the end of each year

More Longduoduo figures